$0.38
(Market cap
$2,026 Mln
Revenue (TTM)
$1,293 Mln
P/E Ratio
33.6
P/B Ratio
4.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
37.33
-
EV/EBITDA
17.6
-
Debt to Equity
0
-
Book Value
$6.2
-
EPS
$0.8
-
Face value
--
-
Shares outstanding
78,332,370
7 Years Aggregate
CFO
$322.71 Mln
EBITDA
$155.93 Mln
Net Profit
$184.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Progyny (PGNY)
| 0.7 | 36.8 | 45.4 | 21.4 | -12.8 | -16.4 | -- |
|
BSE Sensex*
| -13.2 | -5.5 | -6.8 | -10.5 | 5.2 | 7.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Progyny (PGNY)
| 48.9 | -53.3 | 19.4 | -38.1 | 18.8 | 54.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Progyny (PGNY)
|
25.9 | 2,025.7 | 1,293.1 | 67.7 | 5.3 | 13.5 | 33.6 | 4.5 |
| 15.4 | 3,177.5 | 4,257.0 | 19.8 | 0.8 | 10.7 | 153.7 | 15.1 | |
| 62.3 | 30,778.4 | 198,101.0 | -6,443.0 | -4.2 | -30.4 | -- | 1.4 | |
| 289.5 | 74,249.0 | 277,944.0 | 6,288.0 | 3.4 | 13.9 | 2.5 | 1.7 | |
| 3.8 | 2,017.2 | 2,211.2 | -56.9 | -2.6 | -16.7 | -- | 6.2 | |
| 415.5 | 89,890.0 | 200,415.0 | 5,243.0 | 3.8 | 11.9 | 17.6 | 1.9 | |
| 350.1 | 41,997.5 | 137,200.0 | 1,130.0 | 1.5 | 6 | 37.3 | 2.1 | |
| 0.0 | 0.0 | 10.8 | -31.2 | -259.9 | 1164.6 | -- | 8.9 | |
| 190.9 | 10,045.4 | 45,075.0 | 188.0 | 1.0 | 4.5 | 51.7 | 2.3 | |
| 399.5 | 360,052.0 | 449,713.0 | 12,044.0 | 4.1 | 11.3 | 29.9 | 3.5 |
Shareholding Pattern
View DetailsAbout Progyny (PGNY)
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart... cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Read more
-
Executive Chairman
Mr. David J. Schlanger
-
Executive Chairman
Mr. David J. Schlanger J.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Progyny (PGNY)
What is the current share price of Progyny Inc (PGNY) Today?
The share price of Progyny Inc (PGNY) is $25.86 (NASDAQ) as of 05-Jun-2026 16:00 EDT. Progyny Inc (PGNY) has given a return of -12.81% in the last 3 years.
What is the current PB & PE ratio of Progyny Inc (PGNY)?
The P/E ratio of Progyny Inc (PGNY) is 33.58 times as on 05-Jun-2026, a 10 discount to its peers’ median range of 37.33 times.
The P/B ratio of Progyny Inc (PGNY) is 4.54 times as on 05-Jun-2026, a 119 premium to its peers’ median range of 2.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
39.06
|
4.43
|
|
2024
|
30.16
|
3.88
|
|
2023
|
60.53
|
6.79
|
|
2022
|
102.61
|
8.26
|
|
2021
|
76.56
|
19.99
|
What is the 52 Week High and Low of Progyny Inc (PGNY)?
The 52-week high and low of Progyny Inc (PGNY) are Rs 28.75 and Rs 16.10 as of 08-Jun-2026.
What is the market cap of Progyny Inc (PGNY)?
Progyny Inc (PGNY) has a market capitalisation of $ 2,026 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Progyny Inc (PGNY)?
Before investing in Progyny Inc (PGNY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.